CompoAtlas

Hair Bell CAPILLAIRE

Food supplement declared in France, declaration No 2022-4-190, decision dated 6 April 2022

Hair Bell CAPILLAIRE (Institut Claude Bell) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Institut Claude Bell
Food business operator placing the product on the market
B2C
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
2 comprimés
Directions for use
Le matin avec un grand verre d'eau
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Cheveux et ongles

Declaration 325571, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Bambusa bambos (L.) VossExsudatExtrait sec aqueux50 mg
Citrus sinensis (L.) OsbeckFruitExtrait sec aqueux40 mg
Malus pumila Mill.FruitExtrait sec hydroalcoolique30 mg
Vaccinium myrtillus L.FruitExtrait sec hydroalcoolique10 mg

Other active ingredients

NamePer day
L-cystinenot declared
Pectine de pommenot declared
Méthioninenot declared
Hydrolysat de collagène de poissonnot declared
Hydrolysat de kératinenot declared
Acide hyaluroniquenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
D-biotineBiotine (vitamine B8)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Gluconate de cuivreCuivre5,000 µg2,000 µg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Oxyde de zincZinc25 mg15 mg

Additives

E341, E504, E460, E470b

Other ingredients

Proteine de blé hydrolysée, Poudre de pomme

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Institut Claude Bell

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line